+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell Harvesting Market by Application, Product Type, Cell Type, End User - Global Forecast to 2030- Product Image
Cell Harvesting Market by Application, Product Type, Cell Type, End User - Global Forecast to 2030- Product Image
Sale

Cell Harvesting Market by Application, Product Type, Cell Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011252
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cell Harvesting Market grew from USD 2.34 billion in 2024 to USD 2.56 billion in 2025. It is expected to continue growing at a CAGR of 9.26%, reaching USD 3.98 billion by 2030.

Setting the Stage for the Next Generation of Cell Harvesting

The cell harvesting landscape is entering a phase of unprecedented importance, driven by breakthroughs in bioprocessing techniques and a surge in demand for high-quality cellular materials. Stakeholders across industry and academia are converging on the need for robust, scalable harvesting processes that can support applications ranging from regenerative medicine to advanced drug screening. This introduction establishes the foundational context for understanding the forces reshaping cell harvesting and sets the stage for an in-depth exploration of the technological, regulatory, and economic factors at play.

As we embark on this examination, we will unpack the complex interplay between innovative harvesting methods and the evolving requirements of end users. By framing the discourse within the broader biomanufacturing ecosystem, this section underscores how optimized cell collection underpins downstream success in therapeutic development, diagnostic testing, and research initiatives. The goal is to equip decision-makers with the strategic perspective necessary to navigate this rapidly advancing field.

How Technological and Market Forces are Redesigning Harvesting Workflows

Recent years have witnessed transformative shifts that are fundamentally redefining how cells are harvested and applied. Automation and digital integration have moved from optional upgrades to essential components of modern bioprocess workflows, enabling real-time monitoring of cell viability and yield. Simultaneously, the convergence of microfluidic platforms with advanced sensors has introduced unprecedented precision into separation and washing steps, minimizing cell stress and maximizing recovery.

Moreover, the growing emphasis on personalized medicine has spurred demand for tailored harvesting strategies that can accommodate small-batch, patient-specific cell products. In parallel, the rise of single-use systems has streamlined scalability, reducing contamination risks and shortening turnaround times. These combined forces are accelerating the maturation of cell harvesting from a largely manual practice to an integrated, data-driven discipline. Understanding these shifts is crucial for organizations aiming to maintain competitiveness in an environment defined by both rapid innovation and stringent quality expectations.

Navigating the Economic Ripple Effects of 2025 Tariff Policies

The introduction of heightened tariffs in 2025 has reverberated across the cell harvesting supply chain, altering cost structures and procurement strategies. Equipment imports, particularly for sophisticated separation modules and automated counters, have become more expensive, prompting manufacturers to reevaluate sourcing channels. As a result, some organizations have accelerated efforts to localize production and forge strategic partnerships with regional suppliers to mitigate exposure to import levies.

In response to these economic pressures, many stakeholders have prioritized equipment standardization and modular upgrades that can be retrofitted without incurring full import duties on new machinery. This adaptive approach has preserved operational continuity while containing capital expenditures. Additionally, there has been a noticeable shift in consumables procurement, with buyers seeking multi-source agreements to leverage competitive pricing and ensure uninterrupted supply. By analyzing these tariff-driven adjustments, decision-makers can anticipate further cost optimization measures and refine their long-term sourcing strategies.

Decoding Demand Through Application, Product, Cell Type, and End-User Insights

A nuanced understanding of market segmentation illuminates where cell harvesting solutions are most in demand and how product portfolios should be tailored. Within applications, cell banking continues to dominate through its biobanking services and cryopreservation offerings, driven by repositories focused on long-term storage and biopharmaceutical reference materials. Diagnostic use cases leverage both flow cytometry for high-throughput cell counting and molecular diagnostics for targeted genetic assays, creating dual pathways for high-precision harvesting tools. In drug discovery and development, vendors address needs spanning biomarker discovery, preclinical screening, and toxicology studies, each requiring specific harvesting protocols to maintain sample integrity. Meanwhile, in regenerative medicine, cell therapy applications demand sterile, closed-system collection methods, while tissue engineering efforts benefit from scalable suspension harvesting technologies.

Examining the product type segmentation reveals that consumables and reagents such as buffers and solutions, culture media, and enzyme kits remain foundational to consistent cell recovery. At the same time, instruments and equipment including automated cell counters, bioreactors, and centrifuges are increasingly engineered for seamless integration into continuous manufacturing lines. On the basis of cell type, markets segregate into cell lines-such as CHO, HEK293, and HeLa cells-where reproducibility is paramount; immune cells, encompassing both B cells and T cells, which require gentle handling to preserve functionality; primary cells like hematopoietic and mesenchymal stem cells along with peripheral blood mononuclear cells; and pluripotent stem cells, whether embryonic or induced, which demand ultra-clean harvesting environments. Finally, end users range from academic and research institutes, which prioritize flexibility, to biotech and pharma companies seeking validated, scalable solutions, while contract research organizations and hospitals or clinical laboratories balance throughput with regulatory compliance. This segmentation framework provides a strategic lens for aligning product development and marketing efforts with the distinct requirements of each segment.

Unpacking the Regional Puzzle of Demand and Adoption Patterns

Regional dynamics present distinct opportunities and challenges for cell harvesting providers. In the Americas, innovation hubs concentrated in North America are driving demand for cutting-edge automated systems and premium reagents, supported by a mature venture capital environment that accelerates technology adoption. Meanwhile, Latin American stakeholders are gradually scaling up infrastructure investments, creating a growing market for mid-range equipment and locally sourced consumables.

Across Europe, the Middle East, and Africa, regulatory harmonization efforts and pan-regional consortia are fostering a cohesive ecosystem, especially in cell therapy development. Western European markets continue to lead in high-value instrument sales, whereas emerging markets in Eastern Europe and the Gulf region are characterized by cost-sensitive demand and an appetite for adaptable, modular solutions. In the Asia-Pacific region, rapid industrialization in countries such as China, India, and South Korea is accompanied by robust government initiatives to bolster biotechnology infrastructure. Providers are capitalizing on this momentum by establishing regional manufacturing facilities and offering tailored service agreements that address local regulatory and logistical complexities. These diverse regional profiles underscore the importance of a flexible go-to-market strategy that balances global standards with local nuances.

Profiling Market Leaders and Emerging Innovators

Leading industry players are vying for dominance by leveraging complementary strengths across technology portfolios and geographic footprints. One prominent provider has solidified its position through strategic acquisitions, integrating advanced bioreactor platforms and automated cell separation modules under a single service umbrella. Another key competitor differentiates itself by pioneering novel microfluidic devices that enable gentle, label-free cell harvesting, securing partnerships with top academic centers and contract research organizations.

Meanwhile, a third major supplier emphasizes end-to-end solutions, bundling high-throughput centrifuges, standardized reagents, and digital data management software to streamline cell collection workflows. Smaller innovators are carving out niche positions by focusing on specialized cell types, such as primary stem cells, or by offering consumables that are optimized for cryopreservation protocols. Across the board, companies are intensifying R&D investments to enhance process automation, improve throughput, and ensure regulatory compliance, culminating in a competitive landscape defined by both consolidation and targeted specialization.

Strategies for Operational Excellence and Sustainable Growth

Organizations seeking to maintain a competitive edge in cell harvesting should prioritize the integration of automation and data analytics into their workflows. Establishing cross-functional teams that include process engineers, quality specialists, and IT architects will accelerate the design of reproducible, scalable harvesting protocols. Concurrently, adopting a modular equipment strategy-favoring systems that can be upgraded in situ-will minimize capital risk and shorten implementation timelines.

In procurement, diversifying supplier relationships through multi-year contracts and regional partnerships can safeguard against tariff volatility and supply chain disruptions. Investing in strategic collaborations with academic institutions or contract research organizations will foster early access to emerging cell types and harvesting techniques. Finally, embedding sustainability metrics into process evaluations-from energy consumption of centrifuges to single-use plastics recycling-will prepare organizations to meet tightening regulatory requirements and stakeholder expectations for environmental responsibility. Together, these recommendations form a roadmap for operational resilience and market leadership.

Robust Methodology Blending Expert Interviews and Data Triangulation

This research relies on a blended approach of primary and secondary data collection to ensure both breadth and depth of insight. Primary inputs were gathered through interviews with senior scientists, process engineers, and procurement leaders across biopharmaceutical companies, academic laboratories, and clinical research organizations. These discussions provided firsthand perspectives on current challenges, adoption drivers, and anticipated technological advancements.

Secondary research was conducted by reviewing technical publications, regulatory guidelines, and industry white papers, supplemented by analysis of financial reports and patent filings. Data from international trade databases and tariff schedules informed the evaluation of economic impacts on equipment and consumable flows. Quantitative findings were validated through a triangulation process, cross-referencing multiple sources to ensure consistency and accuracy. This rigorous methodology underpins the credibility of the insights presented and lays a transparent foundation for strategic decision-making.

Synthesis of Insights Pointing Toward Agile, Data-Driven Leadership

The evolution of cell harvesting is characterized by rapid technological advancement, shifting economic landscapes, and increasingly segmented customer needs. By dissecting these dynamics across applications, product types, cell categories, and end-users, this executive summary illuminates the strategic imperatives for market participants. Regional and tariff-driven factors further underscore the necessity of adaptable supply chain models and localized engagement strategies.

Ultimately, the synthesis of segmentation, competitive, and regional analyses underscores a singular theme: success in the cell harvesting domain hinges on agility-both organizational and technological. Stakeholders who embrace automation, diversify their supply chains, and invest in sustainable, modular solutions will be best positioned to capture emerging opportunities and navigate future uncertainties. This conclusion consolidates the core findings and sets the stage for actionable investment and operational decisions.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Cell Banking
      • Biobanking Services
      • Cryopreservation
    • Diagnostics
      • Flow Cytometry
      • Molecular Diagnostics
    • Drug Discovery & Development
      • Biomarker Discovery
      • Preclinical Screening
      • Toxicology Studies
    • Regenerative Medicine
      • Cell Therapy
      • Tissue Engineering
  • Product Type
    • Consumables & Reagents
      • Buffers & Solutions
      • Culture Media
      • Enzymes
    • Instruments & Equipment
      • Automated Cell Counters
      • Bioreactors
      • Centrifuges
  • Cell Type
    • Cell Lines
      • CHO Cells
      • HEK293 Cells
      • HeLa Cells
    • Immune Cells
      • B Cells
      • T Cells
    • Primary Cells
      • Hematopoietic Stem Cells
      • Mesenchymal Stem Cells
      • Peripheral Blood Mononuclear Cells
    • Stem Cells
      • Embryonic Stem Cells
      • Induced Pluripotent Stem Cells
  • End User
    • Academic & Research Institutes
    • Biotech & Pharma Companies
    • Contract Research Organizations
    • Hospitals & Clinical Laboratories
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Sartorius AG
  • Lonza Group AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Terumo Corporation
  • Miltenyi Biotec GmbH
  • STEMCELL Technologies Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cell Harvesting Market, by Application
8.1. Introduction
8.2. Cell Banking
8.2.1. Biobanking Services
8.2.2. Cryopreservation
8.3. Diagnostics
8.3.1. Flow Cytometry
8.3.2. Molecular Diagnostics
8.4. Drug Discovery & Development
8.4.1. Biomarker Discovery
8.4.2. Preclinical Screening
8.4.3. Toxicology Studies
8.5. Regenerative Medicine
8.5.1. Cell Therapy
8.5.2. Tissue Engineering
9. Cell Harvesting Market, by Product Type
9.1. Introduction
9.2. Consumables & Reagents
9.2.1. Buffers & Solutions
9.2.2. Culture Media
9.2.3. Enzymes
9.3. Instruments & Equipment
9.3.1. Automated Cell Counters
9.3.2. Bioreactors
9.3.3. Centrifuges
10. Cell Harvesting Market, by Cell Type
10.1. Introduction
10.2. Cell Lines
10.2.1. CHO Cells
10.2.2. HEK293 Cells
10.2.3. HeLa Cells
10.3. Immune Cells
10.3.1. B Cells
10.3.2. T Cells
10.4. Primary Cells
10.4.1. Hematopoietic Stem Cells
10.4.2. Mesenchymal Stem Cells
10.4.3. Peripheral Blood Mononuclear Cells
10.5. Stem Cells
10.5.1. Embryonic Stem Cells
10.5.2. Induced Pluripotent Stem Cells
11. Cell Harvesting Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Biotech & Pharma Companies
11.4. Contract Research Organizations
11.5. Hospitals & Clinical Laboratories
12. Americas Cell Harvesting Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Cell Harvesting Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Cell Harvesting Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Merck KGaA
15.3.3. Danaher Corporation
15.3.4. Sartorius AG
15.3.5. Lonza Group AG
15.3.6. Becton, Dickinson and Company
15.3.7. Bio-Rad Laboratories, Inc.
15.3.8. Terumo Corporation
15.3.9. Miltenyi Biotec GmbH
15.3.10. STEMCELL Technologies Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CELL HARVESTING MARKET MULTI-CURRENCY
FIGURE 2. CELL HARVESTING MARKET MULTI-LANGUAGE
FIGURE 3. CELL HARVESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CELL HARVESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CELL HARVESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CELL HARVESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CELL HARVESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CELL HARVESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CELL HARVESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CELL HARVESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CELL HARVESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CELL HARVESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CELL HARVESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CELL HARVESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL HARVESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL HARVESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CELL HARVESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CELL HARVESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CELL HARVESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CELL HARVESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CELL HARVESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CELL HARVESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL HARVESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CELL HARVESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CELL HARVESTING MARKET SIZE, BY CELL BANKING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CELL HARVESTING MARKET SIZE, BY BIOBANKING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CELL HARVESTING MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CELL HARVESTING MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CELL HARVESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CELL HARVESTING MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CELL HARVESTING MARKET SIZE, BY PRECLINICAL SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CELL HARVESTING MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CELL HARVESTING MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CELL HARVESTING MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CELL HARVESTING MARKET SIZE, BY BUFFERS & SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CELL HARVESTING MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CELL HARVESTING MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CELL HARVESTING MARKET SIZE, BY AUTOMATED CELL COUNTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CELL HARVESTING MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CELL HARVESTING MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CELL HARVESTING MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CELL HARVESTING MARKET SIZE, BY CHO CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CELL HARVESTING MARKET SIZE, BY HEK293 CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CELL HARVESTING MARKET SIZE, BY HELA CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CELL HARVESTING MARKET SIZE, BY B CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CELL HARVESTING MARKET SIZE, BY T CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CELL HARVESTING MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CELL HARVESTING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CELL HARVESTING MARKET SIZE, BY PERIPHERAL BLOOD MONONUCLEAR CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CELL HARVESTING MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CELL HARVESTING MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CELL HARVESTING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CELL HARVESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CELL HARVESTING MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CELL HARVESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CELL HARVESTING MARKET SIZE, BY HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS CELL HARVESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES CELL HARVESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 89. CANADA CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. CANADA CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 91. CANADA CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 92. CANADA CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 93. CANADA CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 94. CANADA CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. CANADA CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 96. CANADA CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 97. CANADA CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 98. CANADA CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 99. CANADA CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 100. CANADA CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 101. CANADA CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 102. CANADA CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. MEXICO CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. MEXICO CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 105. MEXICO CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 106. MEXICO CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 107. MEXICO CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 108. MEXICO CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. MEXICO CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 110. MEXICO CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 111. MEXICO CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 112. MEXICO CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 113. MEXICO CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 114. MEXICO CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 116. MEXICO CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA CELL HARVESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. GERMANY CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. GERMANY CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 176. GERMANY CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 177. GERMANY CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 178. GERMANY CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 179. GERMANY CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. GERMANY CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 181. GERMANY CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 182. GERMANY CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 183. GERMANY CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 184. GERMANY CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 185. GERMANY CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 186. GERMANY CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 187. GERMANY CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. FRANCE CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. FRANCE CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 190. FRANCE CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 191. FRANCE CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 192. FRANCE CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 193. FRANCE CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. FRANCE CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 195. FRANCE CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 196. FRANCE CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 197. FRANCE CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 198. FRANCE CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 199. FRANCE CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 200. FRANCE CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 201. FRANCE CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 205. RUSSIA CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 206. RUSSIA CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. RUSSIA CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. ITALY CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. ITALY CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 218. ITALY CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 219. ITALY CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 220. ITALY CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 221. ITALY CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. ITALY CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 223. ITALY CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 224. ITALY CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 225. ITALY CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 226. ITALY CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 227. ITALY CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 228. ITALY CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 229. ITALY CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. SPAIN CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. SPAIN CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 232. SPAIN CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 233. SPAIN CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 234. SPAIN CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 235. SPAIN CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. SPAIN CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 237. SPAIN CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 238. SPAIN CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 239. SPAIN CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 240. SPAIN CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 241. SPAIN CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 242. SPAIN CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 243. SPAIN CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. SAUDI ARABIA CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 260. SAUDI ARABIA CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 262. SAUDI ARABIA CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 264. SAUDI ARABIA CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 266. SAUDI ARABIA CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. SOUTH AFRICA CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 274. SOUTH AFRICA CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. DENMARK CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. DENMARK CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 288. DENMARK CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 289. DENMARK CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 290. DENMARK CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 291. DENMARK CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 292. DENMARK CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 293. DENMARK CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 294. DENMARK CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 295. DENMARK CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 296. DENMARK CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 297. DENMARK CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 298. DENMARK CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 299. DENMARK CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. NETHERLANDS CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. NETHERLANDS CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 302. NETHERLANDS CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 303. NETHERLANDS CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 304. NETHERLANDS CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 305. NETHERLANDS CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 306. NETHERLANDS CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 307. NETHERLANDS CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 308. NETHERLANDS CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 309. NETHERLANDS CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 310. NETHERLANDS CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 311. NETHERLANDS CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 312. NETHERLANDS CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 313. NETHERLANDS CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. QATAR CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. QATAR CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 316. QATAR CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 317. QATAR CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 318. QATAR CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 319. QATAR CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 320. QATAR CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 321. QATAR CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 322. QATAR CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 323. QATAR CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 324. QATAR CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 325. QATAR CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 326. QATAR CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 327. QATAR CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. FINLAND CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. FINLAND CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 330. FINLAND CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 331. FINLAND CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 332. FINLAND CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 333. FINLAND CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 334. FINLAND CELL HARVESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 335. FINLAND CELL HARVESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 336. FINLAND CELL HARVESTING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 337. FINLAND CELL HARVESTING MARKET SIZE, BY CELL LINES, 2018-2030 (USD MILLION)
TABLE 338. FINLAND CELL HARVESTING MARKET SIZE, BY IMMUNE CELLS, 2018-2030 (USD MILLION)
TABLE 339. FINLAND CELL HARVESTING MARKET SIZE, BY PRIMARY CELLS, 2018-2030 (USD MILLION)
TABLE 340. FINLAND CELL HARVESTING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 341. FINLAND CELL HARVESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 342. SWEDEN CELL HARVESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 343. SWEDEN CELL HARVESTING MARKET SIZE, BY CELL BANKING, 2018-2030 (USD MILLION)
TABLE 344. SWEDEN CELL HARVESTING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 345. SWEDEN CELL HARVESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 346. SWEDEN CELL HARVESTING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 347. SWEDEN CELL HARVESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MI

Companies Mentioned

The companies profiled in this Cell Harvesting market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Sartorius AG
  • Lonza Group AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Terumo Corporation
  • Miltenyi Biotec GmbH
  • STEMCELL Technologies Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.56 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.98 Billion
Compound Annual Growth Rate9.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cell Harvesting System Market Size, Share & Trends Analysis Report By Type (Manual, Automated) By Application (Umbilical Cord, Bone Marrow, Peripheral Blood), By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Cell Harvesting System Market Size, Share & Trends Analysis Report By Type (Manual, Automated) By Application (Umbilical Cord, Bone Marrow, Peripheral Blood), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Cell Harvesting - Global Strategic Business Report - Product Image

Cell Harvesting - Global Strategic Business Report

  • Report
  • 306 Pages
  • Global
From
Cell Harvesting Market Report 2025 - Product Image

Cell Harvesting Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Cell Harvesting System Market by Type, by Application, by End-User, and By Region - Product Image

Cell Harvesting System Market by Type, by Application, by End-User, and By Region

  • Report
  • 200 Pages
  • Global
From
Cell Harvesting System Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Cell Harvesting System Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 207 Pages
  • Global
From

About the Cell Harvesting Market

The Cell Harvesting market within the biotechnology industry is a rapidly growing sector that focuses on the collection and processing of cells for use in research and medical applications. Cell harvesting is a critical step in the production of biopharmaceuticals, such as vaccines, antibodies, and other therapeutic proteins. It involves the collection of cells from a variety of sources, including cell cultures, tissue samples, and blood. The harvested cells are then processed and purified for use in research and medical applications. Cell harvesting technologies have advanced significantly in recent years, allowing for more efficient and cost-effective collection and processing of cells. This has enabled the development of new biopharmaceuticals and other therapeutic products. Companies in the Cell Harvesting market include Thermo Fisher Scientific, Merck KGaA, Sartorius AG, Danaher Corporation, and Becton Dickinson. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.